Sigdel, Tara K.
Sur, Swastika
Boada, Patrick
McDermott, Suzanne M.
Arlehamn, Cecilia S. Lindestam
Murray, Kristy O.
Bockenstedt, Linda K.
Kerwin, Maggie
Reed, Elaine F.
Harris, Eva
Stuart, Ken
Peters, Bjoern
Sesma, Ana
Montgomery, Ruth R.
Sarwal, Minnie M.
Article History
Received: 23 July 2023
Revised: 30 August 2023
Accepted: 24 September 2023
First Online: 13 October 2023
DECLARATIONS
:
: This study was performed in line with the principles of the Declaration of Helsinki. The research was carried out in accordance with the institutional review board approval, and all the participants provided written informed consent. The detailed information is as follows. We received BK virus nephropathy (BKV) samples from kidney transplant recipients consented at UCLA through IRB#11–001387. Cytomegalovirus blood samples and healthy control samples were collected from kidney transplant recipients enrolled at UCSF through IRB approved study #14–13573 and NIH 3U19AI1281913 study entitled “Mapping Immune Responses to CMV in Renal Transplant Recipients.” Study samples from patients with malaria were obtained from Seattle Children’s Research Institute through IRB#20162556. The samples were collected as a part of the Immunization by Mosquito with Radiation Attenuated Sporozoites (IMRAS) trial (NCT01994525). Study samples from the tuberculosis cohort were obtained from La Jolla Institute for Immunology through IRB#VD-143. Dengue study participants in Managua, Nicaragua, were consented through UC Berkeley IRB #2010–06-1649 and the Nicaraguan Ministry of Health IRB# NIC-MINSA/CNDR CIRE-01/10/06–13. Samples from the West Nile virus cohort studies were obtained through H-305333 and 0510000728 at Baylor College of Medicine and Yale School of Medicine. The Lyme disease cohort was obtained through IRB# 1112009475 at Yale School of Medicine.
: Informed consent was obtained from all recruited subjects for publishing the results of the study.
: The authors have no relevant financial or non-financial interests to disclose.